Articles tagged with Antibiotics
Researchers found fecal transplants increase IL-25, reducing tissue inflammation and boosting immune system response to C. difficile infections. The transplants also promote beneficial microbial diversity, helping patients heal from life-threatening diarrhea.
Research shows that common medicines have distinct effects on gut bacteria, with some having beneficial and others detrimental impacts. The study found associations between certain medications and changes to the gut microbiome, particularly with statins and gastric acid medication.
A new study reveals widespread prescribing of clarithromycin-based regimens for H. pylori infection, defying increasing resistance and suboptimal eradication rates. Talicia, a rifabutin-based therapy, offers an alternative with higher eradication rates and fewer concerns over resistance.
Researchers have mapped the atomic structure of amphotericin B, a powerful but toxic antifungal agent. The detailed structure reveals how the drug kills fungal cells by robbing them of sterol molecules, providing a roadmap for synthesizing less-toxic derivatives.
Researchers found that many medications, including antibiotics and cardiometabolic drugs, can significantly alter the human gut microbiome. The study revealed a complex relationship between drug dosage and microbiome impact, highlighting the need for personalized treatment strategies.
Researchers at USC developed a new peptide that stimulates the host's immune response to fight bacterial infections, offering an alternative to antibiotics. The peptide, MTD12813, is highly effective in clearing infections and modulates inflammation, reducing the risk of complications.
Researchers found that gut microbiome changes can reduce b-amyloid deposits in male mice, indicating a potential target for preventing and treating dementia. Daily fecal matter transplants restored the pre-antibiotic microbiome, suggesting microglia memory plays a role.
A new white paper shares practical strategies to inform stewardship efforts and ensure appropriate use of antibiotics, citing the public health crisis of antibiotic resistance leading to 23,000 preventable deaths each year. Implementation science principles can bridge the evidence-practice gap.
A new study led by Rice University engineers finds that microplastic pollution contributes to the spread of antibiotic-resistant genes. The researchers discovered that aging polystyrene breaks down into microplastics with high surface areas, trapping microbes and leaching chemicals that enhance gene transfer.
A recent study found that antibiotic resistance rates for Helicobacter pylori are decreasing in European countries. The use of three antibiotics over 10-14 days resulted in success rates of over 90%. The researchers hope to reduce antibiotic consumption to prevent further resistance.
Researchers from the University of Manchester have discovered a new way to manipulate key assembly line enzymes in bacteria using CRISPR-cas9 gene editing. This approach could lead to the production of improved antibiotics with potentially improved properties, addressing the growing threat of antimicrobial resistance.
Scientists have studied how different drugs affect Pseudomonas aeruginosa, revealing what makes it resistant to antibiotics. A new experimental substance called CHIR-090 has shown promise in blocking the production of sugar-lipid compounds, a previously unexploited target for treatment.
A study led by New York University researchers found that the FDA-approved hepatitis C treatment telaprevir can increase bacterial sensitivity to antibiotics and reduce antibiotic resistance. The antiviral blocks the function of essential proteins in bacteria, revealing an opportunity to repurpose the drug to use alongside antibiotics.
The European Union and European Economic Area saw a significant decline in antibiotic consumption in 2020, with a 18% decrease compared to 2019. This decline was largely attributed to the COVID-19 pandemic, which led to reduced primary care consultations for mild infections.
Researchers at the University of Texas at Dallas have developed a vaccine method against recurrent urinary tract infections (UTIs) using metal-organic frameworks. The new approach produces substantially enhanced antibody production and significantly higher survival rates in mice compared to standard vaccine preparation methods.
Researchers at Hebrew University of Jerusalem discover a 'disrupted' state in bacteria that resists current antibiotics, requiring new pharmacological agents to combat. The breakthrough model predicts bacterial population responses to treatments, offering avenues for better treatments against cancer cells.
A study by Anglia Ruskin University has identified potentially dangerous Pseudomonas bacteria in 21% of wild bird faeces collected from locations near the River Cam. The bacteria, which can be passed on to humans through cross-contamination, were resistant to multiple antibiotics.
Researchers at Karolinska Institutet have discovered a new group of small antibacterial compounds that inhibit the formation of bacterial cell walls, showing promise against antibiotic-resistant strains. The molecules work by binding to lipid II, a crucial molecule for bacterial cell wall construction.
Scientists at the University of Southampton have created nanoparticles that can target and kill deadly bacteria hiding in human cells. The breakthrough could lead to a new treatment method using injectable or inhalation-based antibiotic-laden capsules, potentially saving thousands of lives annually.
A rapid same-day test has been developed to identify secondary infections in COVID-19 patients on intensive care, allowing for targeted antibiotic treatment and reduced risk of antimicrobial resistance. The test uses nanopore sequencing technology to analyze bacterial and fungal pathogens present in patient samples.
A new study found that regular antibiotic treatment with penicillin significantly reduced the risk of underlying rheumatic heart disease progression in children and adolescents. Early screening was critical in preventing serious disease progression and death in young children.
A new study found that low-dose CT scans are as accurate as standard-dose scans in diagnosing appendicitis and differentiating between uncomplicated and complicated cases. This breakthrough could lead to reduced radiation exposure for young patients, improving treatment outcomes.
Research identifies way of using nanoparticles to target and disrupt bacterial cells, making them more susceptible to standard antibiotic treatments. Laboratory studies show a strong effect in killing a range of bacteria, including some linked to hospital-acquired infections.
A new study found that heat and antibiotics alone and in combination degrade soil microbe efficiency, resilience, and ability to trap carbon. This could diminish soils' resilience to future stress and exacerbate climate change effects.
Researchers at Penn discovered a new suite of antimicrobial peptides, hidden within the human genome, which showed promising natural antibiotic potential. The peptides displayed antimicrobial activity against various pathogens, including E. coli and staph infection-causing bacteria.
The need for new antibiotics is critical due to rising antibiotic resistance, which kills over 35,000 people annually in the US. Research by Harvard Medical School aims to develop better antibiotics by targeting essential bacterial proteins.
A new report highlights the alarming global impact of Group B streptococcus, which can lead to up to 150,000 infant deaths annually. Maternal vaccination is seen as a cost-effective solution to reduce this toll, with significant health benefits in all regions.
A study published in The Lancet Infectious Diseases found that temocillin was effective in treating febrile urinary tract infections with fewer resistant bacteria. Temocillin acts specifically against E. coli and other intestinal bacteria, reducing the risk of treatment failure.
A new study reveals that iboxamycin effectively fights both gram-negative and gram-positive drug-resistant bacteria in mouse models. The researchers discovered the molecular mechanism that allows this drug to overcome resistance, which is important for developing new antibiotics.
Scientists found ancient bacteria in permafrost resistant to streptomycin, spectinomycin, chloramphenicol, and tetracycline. Genome analysis revealed limited differences between ancient and modern strains, suggesting a potential threat to human health due to global warming.
Researchers have recorded the sharpest images of living bacteria, revealing a complex architecture that makes them harder to kill by antibiotics. The study found that bacteria with protective outer layers may have stronger and weaker spots on their surface.
The Comparing Outcomes of antibiotic Drugs and Appendectomy (CODA) trial found that nearly 7 in 10 patients with antibiotics avoided an appendectomy within three months. By four years, just under 50% had the surgery, suggesting both treatments are safe and valuable to patients differently based on unique symptoms and circumstances.
Researchers revealed that β-lactam antibiotics like penicillin kill MRSA by forming small holes in the cell wall, which gradually enlarge and lead to bacterial death. This discovery provides new avenues for treatment developments against antibiotic-resistant superbugs.
A new research discovery at Monash University has found a way to make antibiotics more effective against 'superbugs' by attaching chemoattractants to antibiotics, enabling the recruitment of immune cells and improving killing ability. The findings have shown a 2-fold increase in effectiveness with lower doses.
Researchers at Cornell University used machine learning to predict the spread of antibiotic resistance genes among bacteria, identifying potential networks of exchange and driving factors. The approach could help control the spread of antibiotic resistance and develop new targets for novel antibiotics.
Researchers at Berkeley Lab have successfully engineered microbes to produce novel chemicals and developed a new technique for studying enzyme reactions in real-time. This breakthrough could lead to the production of sustainable fuels, pharmaceuticals, and renewable plastics.
Researchers at the University of Bonn discovered a novel resistance mechanism in Staphylococcus aureus, which protects the bacteria from vancomycin. By binding vancomycin to its cell wall, the strain prevents the antibiotic from reaching the membrane and killing the bacteria.
A new study suggests that a novel treatment involving the administration of an enzyme that degrades neutrophil nets may prevent brain swelling and improve waste clearance in rats with bacterial meningitis. The treatment could be combined with antibiotics if needed.
Researchers at the University of Oklahoma have contributed to a study on a new antibiotic that may cure Lyme disease and eradicate its occurrence from the environment. The antibiotic, hygromycin A, targets the ribosomes of the bacteria Borrelia burgdorferi and shows promise in treating the disease.
A new hydrogel treatment kills drug-resistant bacteria, including MRSA, and induces the expression of naturally-existing antimicrobial peptides in human skin cells. The gel is non-toxic, biodegradable, and scalable.
Researchers from EMBL Heidelberg and University of Tübingen discovered that certain antibiotics, like tetracyclines and macrolides, can kill specific gut microbes. Combining antibiotics with non-antibiotic drugs may reduce collateral damage by preserving antibiotic activity against pathogens.
Researchers at the University of Exeter develop a new method to mimic microenvironments in the human body, overcoming a major obstacle to using phage therapy. The study finds that phage can effectively kill bacteria in these environments without promoting genetic resistance.
Researchers tested spider silk from seven species and found no signs of antimicrobial activity, casting doubt on previous reports. The team attributed methodological shortcomings to compromised studies, suggesting that the silk may serve as a physical barrier rather than an intrinsic antimicrobial agent.
A new study by Oxford academics found that approximately 20% of flies and cockroaches carry carbapenem resistance, while 70-80% carry extended spectrum cephalosporin resistance. Climate change could lead to a doubling of insect populations and an increase in the global spread of antibiotic resistance.
Researchers at IOCB Prague have developed a novel antibacterial material called NANO-LPPO that can prevent infection and facilitate treatment of skin wounds. The material combines lipophosphonoxins with a nonwoven nanotextile, which releases active substances in response to bacterial presence.
A large trial found that antibiotic amoxicillin has little effect on relieving symptoms in children with uncomplicated chest infections. The study also highlights the need for 'safety-netting' advice to parents, explaining illness course and when re-attendance may be necessary.
A systematic review found that azithromycin reduced low birth weight and prematurity in Africa and Asia but didn't lower infant deaths or hospital admissions. The study suggests the potential benefits of this intervention on neonatal outcomes may be limited, highlighting the need for further research.
A team of engineers and biotechnologists has developed a biosensor that measures antibiotic levels in breath, mirroring blood concentrations. This breakthrough enables on-site, personalized dosing to minimize resistant bacteria strains.
Researchers at Duke University developed an antibiotic coating that can be applied to orthopedic implants before surgery, eliminating the risk of infection. The coating, made from two polymers and an antibiotic, prevents bacterial colonization and can be personalized for individual patients.
Scientists have developed a new therapy that combines bacteriophages with antibiotics to treat antibiotic-resistant infections, specifically targeting Mycobacterium abscessus. The treatment, using the bacteriophage 'Muddy', showed significant improvement in survival rates and severity of infections when paired with rifabutin, demonstra...
A new study from Cornell University has found that the antimicrobial properties of certain stem cell proteins can effectively reduce the viability of methicillin-resistant Staphylococcus aureus (MRSA) in skin wounds. The treatment also stimulates the surrounding skin cells to build up a defense against the bacterial invader.
A study found that adding melatonin to vancomycin treatment significantly reduces acute kidney injury in hospitalized patients, alleviating oxidative stress and restoring kidney function. The findings could lead to larger therapeutic breakthroughs and pave the way for further clinical studies.
Researchers at Tel Aviv University have created a system that enables the production of 'good' bacteria capable of eliminating 'bad' bacteria. This breakthrough technology uses a toxin injection system to target specific types and amounts of toxins, offering an alternative to antibiotics.
A randomized clinical trial found that yogurt containing Bifidobacterium lactis BB-12 protected against harmful changes in the gut microbiome after antibiotic administration. The study also showed that levels of beneficial short-chain fatty acid acetate returned to baseline within 30 days.
Researchers suggest that protecting the microbiome is crucial in preventing and fighting off infections with harmful, drug-resistant bacteria. By preserving a healthy balance of beneficial microorganisms, individuals can reduce their susceptibility to these types of infections.
Researchers at UC San Diego School of Medicine are studying the impact of antibiotics on breast milk and infant health. The team will investigate how antibiotics alter the composition of breast milk and impact the infant microbiome, metabolome and immune response.
A mechanical engineering faculty-researcher at RIT is developing a microfluidic device to improve the detection of drug-resistant bacteria in blood, which can cause severe infection and death. The goal is to detect these strains early, allowing for prompt treatment and recovery.
Patients with nontuberculous mycobacterial disease are hospitalized sooner and more often than their age- and sex-matched counterparts, according to a study published in CHEST. The risk is higher for people with compromised immune systems or damaged airways.
Researchers found that human antibiotic use increased resistance to antibiotics in bears' bacteria, affecting even those far from civilization. The study suggests that reducing antibiotic use can help decline resistance rates.
A CDC analysis of National Healthcare Safety Network data revealed a significant increase in four types of healthcare-associated infections in U.S. hospitals during the COVID-19 pandemic, with central line infections rising by 46-47% compared to pre-pandemic rates.